Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-23

FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, adding the sprinkle formulation to the product labeling. The app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Depakote Sprinkles (divalproex sodium)

Snippet

SUPPL AP for DEPAKOTE SPRINKLES (DIVALPROEX SODIUM)